This excerpt taken from the ELN 6-K filed Mar 30, 2009.
Research, Development & Commercial Activities
We have developed clear and accountable policies and procedures for all our medical and scientific practices to ensure comprehensive oversight of all our clinical, scientific, pharmacovigilance and medical governance issues is achieved.
We take seriously our ethical and scientific responsibilities and demonstrate these aspects of our work in our relationships with our clinical partners; in this work we have regard of anti-kickback statutes, which prohibit offering payment to induce the purchasing of our products, as well as false claims legislation. In addition, we aim to apply the highest standards in all our clinical and scientific research in every country in which we operate and with every group of stakeholders with whom we interact.
All our clinical trials are conducted according to the Good Clinical Practice guidelines developed by the International Conference on Harmonisation and the principles contained in the World Medical Association Declaration of Helsinki on the Ethical Principles for Medical Research Involving Human Subjects (2004).